戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 edback control of the hypothalamic-pituitary-adrenal axis.
2 mbic centers, and the hypothalamic-pituitary-adrenal axis.
3 ess and regulates the hypothalamic-pituitary-adrenal axis.
4 of CFS, including the hypothalamic-pituitary-adrenal axis.
5 sal regulation of the hypothalamic-pituitary-adrenal axis.
6 ted activation of the hypothalamic-pituitary-adrenal axis.
7  dysregulation of the hypothalamic-pituitary-adrenal axis.
8 ulatory effect in the hypothalamic-pituitary-adrenal axis.
9 pal regulation of the hypothalamic-pituitary-adrenal axis.
10 ing activation of the hypothalamic pituitary adrenal axis.
11 ns in function of the hypothalamic-pituitary-adrenal axis.
12 text of a hyperactive hypothalamic-pituitary-adrenal axis.
13  an equivalent of the hypothalamus-pituitary-adrenal axis.
14 ey to controlling the hypothalamic-pituitary-adrenal axis.
15 ant regulation of the hypothalamic-pituitary adrenal axis.
16 via activation of the hypothalamic-pituitary-adrenal axis.
17 eak activation of the hypothalamic-pituitary-adrenal axis.
18 the regulation of the hypothalamic-pituitary-adrenal axis.
19 etely mediated by the hypothalamic-pituitary-adrenal axis.
20 istent changes in the hypothalamic-pituitary-adrenal axis.
21 e sympathoadrenal and hypothalamic-pituitary adrenal axis.
22  and in particular the hypothalamo-pituitary adrenal axis.
23  context of the limbic-hypothalamo-pituitary adrenal axis.
24 bitory control of the hypothalamic-pituitary-adrenal axis.
25 in the function of the hypothalamo-pituitary-adrenal axis.
26 ons is mediated by the hypothalamo-pituitary-adrenal axis.
27 ich is mediated by the hypothalamo-pituitary-adrenal axis.
28 oid production by the hypothalamic-pituitary-adrenal axis.
29 he hypothalamo-pituitary-adrenal or sympatho-adrenal axis.
30 he hypothalamo-pituitary-adrenal or sympatho-adrenal axis.
31 rons that control the hypothalamic-pituitary-adrenal axis.
32 d to disruption of the hypothalamo-pituitary-adrenal axis.
33 halamic regulator of the endocrine pituitary-adrenal axis.
34 via activation of the hypothalamic pituitary adrenal axis.
35 and activation of the hypothalamic-pituitary-adrenal axis.
36  modulation of the activity of the pituitary-adrenal axis.
37 nterregulatory systems such as the pituitary-adrenal axis.
38 ility to activate the hypothalamic-pituitary-adrenal axis.
39 ced regulation of the hypothalamic-pituitary-adrenal axis.
40  normally functioning hypothalamic-pituitary-adrenal axis.
41  by hormones from the hypothalamic-pituitary-adrenal axis.
42 elated changes to the hypothalamic-pituitary-adrenal axis.
43  these effects to the hypothalamic-pituitary-adrenal axis.
44  the well-established hypothalamic-pituitary-adrenal axis.
45 and controlled by the hypothalamic-pituitary-adrenal axis.
46  the amygdala and the hypothalamic-pituitary-adrenal axis.
47 ons, by affecting the hypothalamic-pituitary-adrenal axis.
48 ajor regulator of the hypothalamic-pituitary-adrenal axis.
49  dysregulation of the hypothalamic-pituitary-adrenal axis.
50 also regulated by the hypothalamic-pituitary-adrenal axis.
51 gnaling and an intact hypothalamic-pituitary-adrenal axis.
52 une activation of the hypothalamic-pituitary-adrenal axis.
53 nse by activating the hypothalamic-pituitary-adrenal axis.
54 ative feedback on the hypothalamic-pituitary-adrenal axis.
55  disinhibition of the hypothalamus-pituitary-adrenal axis.
56 ced activation of the hypothalamic-pituitary-adrenal axis.
57  in the corticotropic (hypothalamo-pituitary-adrenal) axis.
58 ude (1) a hyperactive hypothalamic-pituitary-adrenal axis; (2) structural and functional abnormalitie
59 3) the stress system (hypothalamic-pituitary-adrenal axis), (4) the (gastrointestinal) corticotropin-
60 ase and activates the hypothalamic-pituitary-adrenal axis, a reflex central to the stress response an
61 ons with demonstrable hypothalamic-pituitary-adrenal axis abnormalities.
62 her than an activated hypothalamic-pituitary-adrenal axis, ACTH-independent regulators have been repo
63 d by activation of the hypothalamo-pituitary-adrenal-axis acting in concert with endogenous EAAs from
64 ight loss may decrease hypothalamo-pituitary-adrenal axis activation and reduce glucocorticoid metabo
65 in, representative of hypothalamic-pituitary-adrenal axis activation, and the tyrosine hydroxylase ge
66 nstead of consecutive hypothalamus-pituitary-adrenal axis activation, we report that acute SCI in mic
67 ognition, anxiety and hypothalamic-pituitary-adrenal axis activation.
68 oduced as a result of hypothalamic-pituitary-adrenal axis activation.
69 ced by 2-deoxy-D-glucose (2-DG) on pituitary-adrenal axis activation.
70 plasma CORT following hypothalamic-pituitary-adrenal axis activation.
71 thood with diminished hypothalamic-pituitary-adrenal-axis activation compared with LFD males.
72 ess the role of MR in hypothalamic-pituitary-adrenal axis activity and anxiety-related behaviors, we
73                       Hypothalamic-pituitary-adrenal axis activity and cortisol release are consequen
74 nt role in regulating hypothalamic-pituitary-adrenal axis activity and mediating physiological respon
75 iposity, and abnormal hypothalamic-pituitary-adrenal axis activity could be predisposing factors.
76 nefits for children's hypothalamic-pituitary-adrenal axis activity immediately after treatment.
77 his suggests that low hypothalamic-pituitary-adrenal axis activity is a correlate of severe and persi
78             Increased hypothalamic-pituitary-adrenal axis activity leads to increased levels of gluco
79  hyperresponsivity in hypothalamic-pituitary-adrenal axis activity secondary to hypersecretion of cor
80 elated energy intake, hypothalamic-pituitary-adrenal axis activity, and the glucoregulatory response
81  anxiety behavior and hypothalamic-pituitary-adrenal axis activity, likely through modulation of hipp
82 othesis that maternal hypothalamic-pituitary-adrenal axis activity, measured by hair cortisol concent
83  a capacity to reduce hypothalamic-pituitary-adrenal axis activity.
84 ation, or exacerbated hypothalamic-pituitary-adrenal axis activity.
85 ircadian modulation of hypothalamicpituitary-adrenal axis activity.
86 ession, and increased hypothalamic-pituitary-adrenal axis activity.
87 diated attenuation of hypothalamic-pituitary-adrenal axis activity.
88  key regulator of the hypothalamic-pituitary-adrenal axis, also has proinflammatory effects, apparent
89 mary regulator of the hypothalamic-pituitary-adrenal axis and a key element in the response to stress
90 sed activation of the hypothalamic-pituitary-adrenal axis and a poor antibody response to influenza v
91 ghrelin regulates the hypothalamic-pituitary-adrenal axis and affects anxiety and mood disorders, suc
92 after ablation of the hypothalamic-pituitary-adrenal axis and after high-dose glucocorticoid administ
93 yperactivation of the hypothalamic-pituitary-adrenal axis and altered accumulation of important growt
94 ghrelin regulates the hypothalamic-pituitary-adrenal axis and associated stress-induced behaviors, in
95 hat SEA activates the hypothalamic-pituitary-adrenal axis and augments gustatory neophobic behaviors.
96 findings suggest that hypothalamic-pituitary-adrenal axis and autonomic nervous system hyperreactivit
97 ; in that i.c.v. CRH activates the pituitary-adrenal axis and autonomic nervous system, these respons
98                 Lower hypothalamic-pituitary-adrenal axis and autonomic reactivity to stress has also
99 N Sirt1 activates the hypothalamic-pituitary-adrenal axis and basal GC levels by enhancing the produc
100 patible with enhanced hypothalamic-pituitary-adrenal axis and decreased central sympathetic system ac
101  used to activate the hypothalamic-pituitary-adrenal axis and elevate corticosterone (CORT) levels in
102 ethanol activates the hypothalamic-pituitary-adrenal axis and elevates 3alpha,5alpha-THP in plasma, c
103  dysregulation of the hypothalamic-pituitary-adrenal axis and hippocampus and implicate corticotropin
104  Dysregulation of the hypothalamic pituitary adrenal axis and hyperactivity of the subgenual cortex a
105 d with a dysregulated hypothalamic-pituitary adrenal axis and hypocortisolemia.
106 ng alterations in the hypothalamic-pituitary-adrenal axis and inflammatory cytokines, which may contr
107 ted by inhibiting the hypothalamic-pituitary-adrenal axis and inflammatory responses to stress.
108 mbine to activate the hypothalamic-pituitary-adrenal axis and influence impulsivity.
109 sponsive, such as the hypothalamic-pituitary-adrenal axis and neuroimmune function.
110 the microbiota on the hypothalamic-pituitary-adrenal axis and neuroimmune system.
111 ne (CRH), through the hypothalamic pituitary adrenal axis and other brain stress systems, is involved
112 onnection between the hypothalamic-pituitary-adrenal axis and RCT that can be triggered by a stress-i
113 alivary biomarkers of hypothalamus-pituitary-adrenal axis and sympathetic nervous system (SNS) activi
114 c nervous system, the hypothalamic-pituitary-adrenal axis and the cardiovascular, metabolic, and immu
115 sed on studies of the hypothalamic-pituitary-adrenal axis and the noradrenergic system.
116 the activation of the hypothalamus-pituitary-adrenal axis and the potentiation of acute-phase protein
117 ve was to examine the hypothalamic-pituitary-adrenal axis and the subjective and physiologic response
118 the activation of the hypothalamus-pituitary-adrenal axis and the sympathetic nervous system followin
119 responsiveness of the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system may repr
120 ressors stimulate the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system, resulti
121  in PVH, including the hypothalamo-pituitary-adrenal axis and the sympathoadrenal system.
122 of opioid drugs on the hypothalamo-pituitary-adrenal axis and their negative effects on bone health a
123  stimuli activate the hypothalamic-pituitary-adrenal axis and through which cortisol feedback modulat
124 ohorts, activated the hypothalamic-pituitary-adrenal axis, and caused reactivation of latent HSV type
125 ts in the adrenergic, hypothalamic-pituitary-adrenal axis, and neuropeptide Y systems.
126 ction, activity of the hypothalamo-pituitary-adrenal axis, and sympathovagal balance in 11 young men
127 , we have studied the hypothalamic-pituitary-adrenal axis, and the activities of the 11beta-hydroxyst
128 region modulating the hypothalamic-pituitary-adrenal axis-and somatosensory, viscerosensory, and inte
129 nabinoid systems; the hypothalamus-pituitary-adrenal axis; and adenosine and nitric oxide signaling.
130 stems, especially the hypothalamic-pituitary-adrenal axis, as a diathesis for suicide.
131  be independent of the hypothalamo-pituitary-adrenal axis, as both adrenalectomized and sham-operated
132 omote arousal via the hypothalamic-pituitary-adrenal axis, but rather probably acts via brainstem crh
133 urther activity in the hypothalamo-pituitary-adrenal axis, but the chronic actions (across days) of t
134 ons by regulating the hypothalamic-pituitary-adrenal axis, but the mechanisms of inhibition of hypoth
135 eroid release via the hypothalamic-pituitary-adrenal axis) by alcohol intoxication and withdrawal and
136                   The hypothalamic-pituitary-adrenal axis can affect renal Na(+) homeostasis on multi
137 t the activity of the hypothalamic-pituitary-adrenal axis can be influenced by classical (Pavlovian)
138 opment of the mouse's hypothalamic-pituitary-adrenal axis can be modified by neonatal rearing conditi
139 ress responses of the hypothalamic-pituitary-adrenal axis can produce adverse effects on the brain.
140 gents can disrupt the hypothalamic-pituitary-adrenal axis, cause thyroid abnormalities, and result in
141 responses to standard hypothalamic-pituitary-adrenal axis challenge tests in adult female survivors o
142 d hypoactivity of the hypothalamic-pituitary-adrenal axis constitute other findings, but the question
143 ovascular system, and hypothalamic pituitary adrenal axis, contribute both to pathogenesis of disease
144 s hormone system, the hypothalamic-pituitary-adrenal axis, contributes to variability in stress-relat
145  in key relays of the hypothalamic-pituitary-adrenal axis could contribute to the brain's region-spec
146 ed suppression of the hypothalamic-pituitary-adrenal axis coupled with increased glucocorticoid trans
147 basal activity of the hypothalamic-pituitary-adrenal axis, CRF mRNA expression in the central nucleus
148 a reactivation of the hypothalamic-pituitary-adrenal axis during acute withdrawal.
149 al that impairment of hypothalamic-pituitary-adrenal axis during depression can lead to olfactory def
150 ce the function of the hypothalamo-pituitary-adrenal axis during hypoxemic challenges to homeostasis
151 for activation of the hypothalamic-pituitary-adrenal axis during immunological challenge in the absen
152 we review the role of hypothalamic-pituitary-adrenal axis dysfunction in the neurobiology of ill-heal
153 vidence suggests that hypothalamic-pituitary-adrenal axis dysfunction might play an important role in
154         Specifically, hypothalamic-pituitary-adrenal axis dysfunction, enhanced inflammation and oxid
155                       Hypothalamic-pituitary-adrenal axis dysregulation and decreased neurogenesis ar
156 ; it is possible that hypothalamic-pituitary-adrenal axis dysregulation is an important mechanism.
157 h the hypothesis that hypothalamic-pituitary-adrenal axis dysregulation may be a risk factor for poor
158 with both biological (hypothalamic-pituitary-adrenal axis dysregulation) and psychosocial processes (
159 thetic activation and hypothalamic-pituitary-adrenal axis dysregulation, have been linked to arterial
160 with several types of hypothalamic-pituitary-adrenal axis dysregulation.
161  end-effectors of the hypothalamic-pituitary-adrenal axis, endogenous glucocorticoids also play an im
162 atory elements of the hypothalamic-pituitary-adrenal axis expressed in mammalian skin.
163 ised, and GR-mediated hypothalamic-pituitary-adrenal axis feedback is desensitized (as in the case of
164 ressant drugs improve hypothalamic-pituitary-adrenal axis feedback regulation and reduce plasma gluco
165 ly, we found impaired hypothalamic-pituitary-adrenal axis feedback, blunted sympathetic responsivenes
166 ytokines activate the hypothalamic-pituitary-adrenal axis for glucocorticoid release, and these hormo
167 nts was impaired, but hypothalamic-pituitary-adrenal axis function did not differ from that of contro
168  suggest that altered hypothalamic-pituitary-adrenal axis function due to preterm birth may be a sign
169                       Hypothalamic-pituitary-adrenal axis function was probed using a dexamethasone/c
170 oendocrine markers of hypothalamic-pituitary-adrenal axis function were examined in a sample of 122 c
171 lammation, attenuated hypothalamus-pituitary-adrenal axis function, cognitive impairment, and large a
172 noamine transmission, hypothalamus-pituitary-adrenal axis function, immune function, neurogenesis, mi
173 l upward resetting of hypothalamic-pituitary-adrenal axis function.
174 s without influencing hypothalamic-pituitary-adrenal axis function.
175  (GR) sensitivity and hypothalamic-pituitary-adrenal axis functioning and has been associated with ma
176 imary effector of the hypothalamus-pituitary-adrenal axis, has been proposed as a means by which trau
177 neuroregulator of the hypothalamus-pituitary-adrenal axis, has broad central and peripheral distribut
178 l (as a marker of the hypothalamic-pituitary-adrenal axis), heart rate variability (as a marker of th
179 nown to influence the hypothalamic-pituitary-adrenal axis, here we test whether PFC and amygdala resp
180 the regulation of the hypothalamus-pituitary-adrenal axis hormones and that it augments CRS-induced o
181 al subiculum inhibits hypothalamic-pituitary-adrenal axis (HPA) activity following psychological, but
182 in mice activates the hypothalamic-pituitary-adrenal axis (HPA) and induces long-term behavioral chan
183 tor (LIF), affects the hypothalamo-pituitary-adrenal axis (HPA) by stimulating in vitro and in vivo p
184 ethanol activates the hypothalamic pituitary adrenal axis (HPA) causing release of glucocorticoids.
185 dulate activity of the hypothalamo-pituitary-adrenal axis (HPA) following stress, but the regulatory
186 pecific behaviors and hypothalamic-pituitary-adrenal axis (HPA) function in the offspring.
187        It inhibits the hypothalamo-pituitary-adrenal axis (HPA) in several animal models, however, th
188  anxious behavior and hypothalamic-pituitary-adrenal axis (HPA) responses to acute stress.
189 atory features to the hypothalamic-pituitary-adrenal axis (HPA) stress response.
190 h propranolol and the hypothalamic-pituitary-adrenal axis (HPA) with mifepristone.
191 the stress responsive hypothalamic-pituitary-adrenal axis (HPA).
192 rgic, neurons induced hypothalamic-pituitary-adrenal axis hyperactivity and reduced fear- and anxiety
193 glial activation, and hypothalamic-pituitary-adrenal axis hyperactivity in stress vulnerability.
194  of activation of the hypothalamus-pituitary-adrenal axis, hypoglycemia, serum amyloid A production,
195 one and stimulate the hypothalamic-pituitary-adrenal axis in circumstances such as pain, hypoxia or h
196  insufficiency of the hypothalamic-pituitary-adrenal axis in critical illness, which is diagnosed by
197 tion of CXCL5, suggesting a key role for the adrenal axis in driving CXCL5 expression and pulmonary n
198 responsiveness of the hypothalamic-pituitary-adrenal axis in individual patients generally remained w
199 for activation of the hypothalamic-pituitary-adrenal axis in response to stress, and has been a targe
200 the activation of the hypothalamic-pituitary-adrenal axis in response to systemic inflammation.
201  acutely activate the hypothalamic pituitary adrenal axis in unstressed CD-1 mice or have the abortiv
202  abnormalities in the hypothalamic-pituitary-adrenal axis, including signaling by corticotropin-relea
203 nic stress alters the hypothalamic-pituitary-adrenal axis, increases gut motility, and increases the
204    In the case of the hypothalamic-pituitary-adrenal axis, induction of c-fos and/or NGFI-B mRNAs in
205 , end products of the hypothalamic-pituitary-adrenal axis, influence functions of virtually all organ
206  the anti-inflammatory hypothalamo-pituitary-adrenal axis, inhibition of both the production and hypo
207 hat neurogenesis, via hypothalamic-pituitary-adrenal axis interactions, is directly involved in preci
208                   The hypothalamic-pituitary-adrenal axis is a dynamic system regulating glucocortico
209                   The hypothalamic-pituitary-adrenal axis is a key regulatory pathway in the maintena
210                   The hypothalamic-pituitary-adrenal axis is a pivotal component of an organism's res
211 ugh activation of the hypothalamic-pituitary-adrenal axis is associated with a large variety of stres
212  factor (CRF) and the hypothalamic-pituitary-adrenal axis is controlled by the master circadian pacem
213           Herein, the hypothalamic-pituitary-adrenal axis is essential.
214 rating that the fetal hypothalamic-pituitary-adrenal axis is fully functional when the genitalia diff
215 ack regulation of the hypothalamic-pituitary-adrenal axis is not impaired.
216  hyperactivity of the hypothalamic-pituitary-adrenal axis is one of the most consistent biological fi
217                   The hypothalamus-pituitary-adrenal axis is sensitive to changes in the early-life e
218  dysregulation of the hypothalamic-pituitary-adrenal axis, leading to changes in glucocorticoid relea
219 catecholaminergic and hypothalamic-pituitary-adrenal axis leads to splenic atrophy and contraction of
220  normalisation of the hypothalamic-pituitary-adrenal axis, maintenance of pituitary function, and avo
221  of evidence that the hypothalamic-pituitary-adrenal axis may influence the behavioral expression of
222  dysregulation of the hypothalamic-pituitary-adrenal axis may play a role.
223 nsmitter systems, the hypothalamic-pituitary-adrenal axis, metabolic hormonal pathways, inflammatory
224                   The hypothalamic-pituitary-adrenal axis modulates immunity in response to stress.
225 ack regulation of the hypothalamic-pituitary-adrenal axis occurs through a dual-receptor system of mi
226 iety behavior and the hypothalamic-pituitary-adrenal axis of C57BL/6 mice.
227 idual elements of the hypothalamic pituitary adrenal axis on the pathogenesis of hypoglycemia-associa
228 k between CRF and the hypothalamic-pituitary-adrenal axis, on the one hand, and stress (including str
229 nal cascade along the hypothalamic-pituitary-adrenal axis orchestrates bodily responses to stress.
230 e of an immune system-hypothalamic-pituitary-adrenal axis pathway for regulating endogenous responses
231 iet induced the fetal hypothalamic-pituitary-adrenal axis per se.
232 sion to study whether hypothalamic-pituitary-adrenal axis perturbation could be sufficient to provoke
233 the activation of the hypothalamic pituitary adrenal axis plays an important role in stimulating IL-6
234 its activation of the hypothalamic-pituitary-adrenal axis, plays a key role in engaging the transitio
235 ) and function of the hypothalamic-pituitary-adrenal axis predict later psychopathology.
236 sity ES at hindlimb regions drives the vagal-adrenal axis, producing anti-inflammatory effects that d
237  the stress-responsive hypothalamo-pituitary-adrenal axis raises the possibility that cocaine-related
238 ys, suggesting normal hypothalamic-pituitary-adrenal axis reactivity to painful stressors in CBP pati
239                   The hypothalamic-pituitary-adrenal axis regulates mammalian stress responses by sec
240                   The hypothalamic-pituitary-adrenal axis regulates the synthesis and secretion of co
241 uch as by influencing hypothalamic-pituitary-adrenal axis regulation and cortisol dynamics, the auton
242  central component of hypothalamic-pituitary-adrenal axis regulation that prepares the organism for s
243 ay overlap with GR in hypothalamic-pituitary-adrenal axis regulation, but they dissociate significant
244 ein 51 is involved in hypothalamic-pituitary-adrenal axis regulation.
245 ulate the hypothalamic-pituitary-thyroid and adrenal axis, respectively.
246           We conclude that the hamster brain-adrenal axis responds rapidly to changes in photoperiod,
247  with an insufficient hypothalamic-pituitary-adrenal axis response and the optimum treatment for this
248 lack of difference in hypothalamic pituitary adrenal axis response between the cocaine-dependent and
249 information mediating hypothalamic-pituitary-adrenal axis response habituation to repeated loud noise
250     Evaluation of the hypothalamic-pituitary-adrenal axis response in these animals revealed an incre
251 novelty have a larger hypothalamic-pituitary-adrenal axis response than do nonfearful individuals.
252 g and terminating the hypothalamic-pituitary-adrenal axis response to both acute and repeated stress.
253 r impairment of their hypothalamic-pituitary-adrenal axis response to stress than that of the CRFR1-m
254 n cocaine craving and hypothalamic-pituitary-adrenal axis responses are each associated with specific
255 knockdown had reduced hypothalamic-pituitary-adrenal axis responses to both acute and chronic stress
256 robust behavioral and hypothalamic-pituitary-adrenal axis responses to DR infusion of NBI 35965 and C
257 raving and associated hypothalamic-pituitary-adrenal axis responses to evaluate cocaine relapse prope
258  group showed altered hypothalamus-pituitary-adrenal axis responses to stress, evidenced by lower ACT
259 nuated behavioral and hypothalamic-pituitary-adrenal axis responses to stress.
260 related behaviors and hypothalamic-pituitary-adrenal axis responses.
261  subsequent offspring hypothalamic-pituitary-adrenal-axis responsivity.
262  of CGRP activates the hypothalamo-pituitary-adrenal axis resulting in increased corticosterone secre
263  stimuli activate the hypothalamic-pituitary-adrenal axis resulting in increased steroidogenic activi
264 ogical changes in the hypothalamic-pituitary-adrenal axis, reward processing in the brain, and possib
265  modifications of the hypothalamic-pituitary-adrenal axis shape amygdala-mPFC circuitry.
266 se examination of the hypothalamic-pituitary-adrenal axis showed that MC3-R(-/-) mice exhibit elevate
267 corticoid release via hypothalamus-pituitary-adrenal axis stimulation.
268 gnificantly increased hypothalamic-pituitary-adrenal axis stress response and impaired sensorimotor g
269 mitter system and the hypothalamic-pituitary-adrenal axis stress-response system in the diathesis for
270 edback control of the hypothalamus-pituitary-adrenal axis suggests that PP5 may be an important modul
271 ic preparations had documented hypopituitary-adrenal axis suppression.
272 functions altered the hypothalamic-pituitary-adrenal axis, sympathetic adrenal-medullary activation a
273 opin-releasing factor/hypothalamic-pituitary-adrenal axis system, as assessed by 24-hour urinary cort
274 gon secretion, and the hypothalamo-pituitary-adrenal axis that is commonly impaired in diabetes.
275 opioid system and the hypothalamic-pituitary-adrenal axis that may contribute to the development of n
276 he dysfunction of the hypothalamic-pituitary-adrenal axis that occurs during critical illness.
277 al differences in the hypothalamic-pituitary-adrenal axis that underlie propensities for aggression,
278 C), the amygdala, and hypothalamic-pituitary-adrenal axis, the precise genetic and experiential contr
279 abetes influences the hypothalamic-pituitary-adrenal axis, the role of this neuroendocrine system in
280 the regulation of the hypothalamic-pituitary-adrenal axis, thereby affecting an individual's ability
281 ing activation of the hypothalamic-pituitary-adrenal axis through direct projections to paraventricul
282  immune system is the hypothalamic-pituitary-adrenal axis, through the hormones of the neuroendocrine
283 a might sensitise the hypothalamic-pituitary-adrenal axis to development of persistent central fatigu
284 itical element of the hypothalamic-pituitary-adrenal axis to provide effective glucocorticoid-depende
285 in turn activates the hypothalamic-pituitary-adrenal axis to release corticosteroids.
286 ic nervous system and hypothalamic-pituitary-adrenal axis) transcription factor activation.
287 , which activates the hypothalamic-pituitary-adrenal axis under stress, also has proinflammatory peri
288 luence of CRF and the hypothalamic-pituitary-adrenal axis upon the circadian pacemaker is less well e
289 er, activation of the hypothalamic-pituitary-adrenal axis using restraint stress did not activate the
290 ory regulation of the hypothalamic-pituitary-adrenal axis via hypothalamic glutamatergic neurons and
291 asting changes in the hypothalamic-pituitary-adrenal axis, we found that social recognition memory wa
292 tokine activating the hypothalamic-pituitary-adrenal axis, were markedly increased (495 +/- 131 vs. 2
293 is suppression of the hypothalamic-pituitary-adrenal axis, which can lead to adrenal insufficiency.
294 e system includes the hypothalamic-pituitary-adrenal axis, which centrally drives glucocorticoid prod
295 e and the tone of the hypothalamic-pituitary-adrenal axis, which might negatively affect the cardiova
296 pid activation of the hypothalamic-pituitary-adrenal axis, which typically resolves within 60-90 min
297 ing activation of the hypothalamic-pituitary-adrenal axis with atherosclerosis are not well-understoo
298 The activation of the hypothalamic-pituitary-adrenal axis with cocaine appears to depend on feed-forw
299 ng alterations in the hypothalamic-pituitary-adrenal axis with suicidal behavior.
300 d inactivation of the hypothalamic-pituitary-adrenal axis, without affecting energy expenditure or gl

 
Page Top